Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

28. Februar 2024 08:30 ET | Quelle: Dyadic International, Inc.

Dyadic Announces Strategic Partnership Agreement to Develop Affordable Rabies Prophylactics and Vaccines Using its Proprietary C1 Cell Microbial Protein Production Platform

JUPITER, Fla. and BUNNIK, the Netherlands, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company...
04. Oktober 2022 08:45 ET | Quelle: Dyadic International, Inc.

Dyadic to Present Disruptive C1 Technology at World Vaccine Congress Europe Announcing Expansion of Influenza Pipeline with Enhanced Efficacy Potential

JUPITER, Fla., Oct. 04, 2022 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial...
17. September 2020 17:10 ET | Quelle: Animal Hospital of Sullivan County

Animal Hospital Announces Charity Rabies Clinic

FERNDALE, N.Y., Sept. 17, 2020 (GLOBE NEWSWIRE) -- Animal Hospital of Sullivan County is partnering with Warrior Companion to offer rabies vaccinations to pet owners in Ferndale and the surrounding...